Preliminary study of patterns of medication use for depression treatment in China

Asia-Pacific Psychiatry

Volumn 5, Issue 4, 2013, Pages 231-236

  Zhang, Ying ^a   Becker, Thomas ^a   Kösters, Markus ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Antidepressant drug; China; Prescription; Review; Trend

Indexed keywords

ANTIDEPRESSANT AGENT; DEANXIT; FLUOXETINE; FLUPENTIXOL; MELITRACEN; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNCLASSIFIED DRUG; VENLAFAXINE;

CHINA; DEPRESSION; DRUG USE; EVIDENCE BASED PRACTICE; GEOGRAPHIC DISTRIBUTION; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREND STUDY; URBAN AREA;

ANTIDEPRESSANT DRUG; CHINA; PRESCRIPTION; REVIEW; TREND;

ANTHRACENES; ANTIDEPRESSIVE AGENTS; CHINA; DATABASES, BIBLIOGRAPHIC; DEPRESSIVE DISORDER; DRUG COMBINATIONS; DRUG UTILIZATION; FLUPENTHIXOL; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; SEROTONIN UPTAKE INHIBITORS;

EID: 84886813005     PISSN: 17585864     EISSN: 17585872     Source Type: Journal    
DOI: 10.1111/appy.12022     Document Type: Review

References (25)

1. Anand S., Fan V.Y., Zhang J.H., etal. (2008) China's human resources for health: quantity, quality, and distribution. Lancet. 372, 1774-1781.
2. Barbui C., Campomori A., D'Avanzo B., Negri E., Garattini S. (1999) Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates. Soc Psychiatry Psychiatr Epidemiol. 34, 152-156.
3. Bauer M., Monz B.U., Montejo A.L., etal. (2008) Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) study. Eur Psychiatry. 23, 66-73.
4. Chen X.Q., Jin Y.Y., Tang G. (2003) New Pharmacy. People's Medical Publishing House, Beijing.
5. China Center for Pharmaceutical International Exchange (2009) Chinese psychiatrists get world-class support. China Pharmaceutical Newsletter. V, 11-12.
6. China Medical System Holdings Limited (2011) 2011 Annual report. [Cited 20 Sep 2012.] Available from URL: http://en.cms.net.cn/reports/E%20CM%20MAR%2019%20REPORT.pdf.
7. Chinese Medical Association (2007) Guidelines of Prevention and Treatment of Depression. Peking University Medical Press, Beijing Chinese Pharmacopeia Commission, 2000. Chinese Pharmacopoeia. Chinese Pharmacopoeia Medicine Science and Technology Press, Beijing.
8. He J., Jin Z., Yu D. (2009) Statistical reporting in Chinese biomedical journals. Lancet. 373, 2091-2093.
9. Hu T.W., He Y., Zhang M., Chen N. (2007) Economic costs of depression in China. Soc Psychiatry Psychiatr Epidemiol. 42, 110-116.
10. Kroenke K., West S.L., Swindle R., etal. (2001) Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. JAMA. 286, 2947-2955.
11. Rudan I., Chan K.Y., Zhang J.S.F., etal. (2010) Causes of deaths in children younger than 5 years in China in 2008. Lancet. 375, 1083-1089.
12. Sim K., Lee N.B., Chua H.C., etal. (2007) Newer antidepressant drug use in East Asian psychiatric treatment settings: REAP (Research on East Asia Psychotropic Prescriptions) Study. Br J Clin Pharmacol. 63, 431-437.
13. Su F.L., Li H.D. (2007) Advance in search for pharmacokinetics of an antidepressant: venlafaxine. Chin J Clin Pharmacol. 23, 223-226.
14. Uchida N., Chong M.Y., Tan C.H., etal. (2007) International study on antidepressant prescription pattern at 20 teaching hospitals and major psychiatric institutions in East Asia: Analysis of 1898 cases from China, Japan, Korea, Singapore and Taiwan. Psychiatry Clin Neurosci. 61, 522-528.
15. Wang Y. (2005) Progress and Evaluation of Application of Antidepressant Drugs. Evaluation and analysis of drug-use in hospitals of China. 5, 81-84.
16. Wang Z.X. (2003) Pharmacology and Clinical Evaluation of Antidepressant. Evaluation and analysis of drug-use in hospitals of China. 3, 268-270.
17. Wijkstra J., Lijmer J., Balk F., Geddes J., Nolen W.A. (2005) Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev. (4)CD004044doi: 10.1002/14651858.CD004044.pub2.
18. World Health Organization (2003) WHO International Working Group for Drug Statistics Methodology, WHO Collaborating Centre for Drug Statistics Methodology, & WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. Introduction to Drug Utilization Research, Oslo.
19. Wu W.P. (2010) Application and development of drugs in the treatment of depression. Chinese Remedies and Clinics. 10, 1260-1262.
20. Zhang J.Z. (2003) Progress of anti-depressive agents abroad and the present indigenous situation of localization. Shanghai Med Pharm J. 24, 270-273.
21. Zhang L. (2003) Market analysis of fluoxetine. J China Pharm. 14, 523-525.
22. Zhang M.Y. (2011) The treatment rate of depression is not high. Chin J Psychiatry. 1, 19-20.
23. Zhang W.X., Shen Y.C., Li S.R. (1998) Epidemiological investigation on mental disorders in seven areas of China. Chin J Psychiatry. 31, 69-71.
24. Zhao Z.H. (2009) Investigation of present situation and prospect of depressive disorder in China. J Clin Psychiatry. 19, 63-64.
25. Zhao Z.H., Huang Y.Q., Li J., etal. (2009) An epidemiological survey of mental disorders in Guangzhou area. Chin J Nerv Ment Dis. 35, 530-534.